In a major step toward improving the safety and quality of blood transfusion services, the Indian Pharmacopoeia Commission (IPC) is launching a series of sensitisation programmes and webinars to train and guide officials from blood centres across India. The initiative aims to strengthen awareness, promote compliance, and ensure adherence to national and international quality standards for blood and its components.
Under the Drugs Rules, 1945, both blood and blood components are legally classified as drugs, as they are derived, prepared, or separated from human donors. Recognising their vital role in healthcare, the IPC has established comprehensive general requirements and monographs. These scientifically validated standards ensure that every unit of blood or component meets rigorous safety benchmarks. These measures are designed to minimise transfusion-transmitted infections (TTIs) and uphold patient safety across all transfusion services.
National Webinar Marks the Launch of the Initiative
The nationwide sensitisation drive will officially begin with a National Webinar on November 7, 2025. This inaugural event will bring together experts from the IPC, drug regulatory authorities, and specialists in transfusion medicine to discuss critical updates and best practices in blood safety management.
A key highlight of the webinar will be discussions on the Gazette Notification GSR 166(E): Drugs and Cosmetic (Second Amendment) Rules, 2020. The notification was issued on March 11, 2020. The programme will also feature sessions on the newly introduced quality standards for blood and blood components in the Indian Pharmacopoeia (IP). This marks an important milestone in the nation’s commitment to blood safety.
Key Topics and Interactive Learning Sessions
The webinar will cover a range of essential topics, including:
*Understanding quality standards for blood and blood components introduced in the Indian Pharmacopoeia.
*Expert-led discussions on transfusion medicine practices and regulatory compliance.
I*nteractive Q&A sessions addressing technical, procedural, and compliance-related queries from participants.
By combining expert insights with regulatory guidance, the IPC aims to create a collaborative platform for continuous learning and quality improvement in blood transfusion practices.
Strengthening Regulatory Compliance and Institutional Capacity
The sensitisation programmes aim to help transfusion service providers enhance regulatory compliance. They offer step-by-step guidance on implementing quality control measures. The initiative aligns with global best practices to strengthen blood transfusion safety. It empowers healthcare institutions to uphold the highest standards of safety, reliability, and efficacy in every procedure.
The initiative will especially benefit:
*Professionals from blood banks and transfusion centres.
*Regulatory officers overseeing compliance.
*Institutions conducting irradiation of blood components.
*Researchers and academicians in transfusion medicine.
Promoting Trust and Safety in India’s Healthcare System
According to an IPC official, “These sessions help ensure that every blood transfusion in India is safe, effective, and of uncompromising quality, strengthening public confidence in the nation’s healthcare system.” As reported by pharmabiz.com, the IPC has launched this proactive national effort to strengthen blood safety. Through this initiative, the IPC reaffirms its strong commitment to safety and accountability. It aims to build a culture of quality excellence across India’s healthcare and transfusion ecosystem.